Results 101 to 110 of about 929 (159)

PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. [PDF]

open access: yesJ Clin Med
Beck DB   +14 more
europepmc   +1 more source

Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD. [PDF]

open access: yesFront Immunol
Fonseca-Santos M   +27 more
europepmc   +1 more source

VEXAS Syndrome: An Overlooked Threat

open access: yesBalkan Medical Journal
Ugurlu, Serdal, Kilic, Berkay
openaire   +4 more sources

Home - About - Disclaimer - Privacy